Takuya Tsunoda Selected Research

Takuya Tsunoda Research Topics

Disease

78	Neoplasms (Cancer) 05/2024 - 03/2002
17	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 03/2002
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 10/2008
9	Testicular Neoplasms (Testicular Cancer) 01/2018 - 08/2005
8	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2002
8	Stomach Neoplasms (Stomach Cancer) 12/2021 - 03/2002
7	Colonic Neoplasms (Colon Cancer) 01/2024 - 12/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2021
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2008
5	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 11/2007
5	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2002
4	Carcinoma (Carcinomatosis) 05/2024 - 07/2004
4	Esophageal Squamous Cell Carcinoma 04/2014 - 07/2008
2	Lobular Carcinoma 01/2024 - 12/2022
2	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2022
2	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 08/2005
2	Rectal Neoplasms (Rectal Cancer) 09/2023 - 08/2022
2	Obesity 01/2023 - 07/2022
2	Diarrhea 11/2022 - 03/2022
2	Disease Progression 08/2022 - 12/2021
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2022 - 01/2005
2	Residual Neoplasm 02/2022 - 04/2014
2	Melanoma (Melanoma, Malignant) 02/2021 - 03/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2014 - 12/2008
1	Alopecia (Baldness) 05/2024
1	Glioma (Gliomas) 12/2023
1	Triple Negative Breast Neoplasms 11/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023

Drug/Important Bio-Agent (IBA)

30	Peptides (Polypeptides)IBA 11/2023 - 07/2003
21	EpitopesIBA 05/2018 - 07/2003
21	AntigensIBA 01/2018 - 07/2003
14	Immune Checkpoint InhibitorsIBA 01/2024 - 09/2019
12	Methionine (L-Methionine)FDA Link 05/2024 - 08/2022
12	Complementary DNA (cDNA)IBA 06/2016 - 07/2003
11	L-methionine gamma-lyaseIBA 05/2024 - 05/2022
11	Messenger RNA (mRNA)IBA 02/2022 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2021
9	Cancer VaccinesIBA 01/2016 - 07/2003
8	Protein Subunit VaccinesIBA 11/2023 - 11/2008
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
6	Carrier Proteins (Binding Protein)IBA 06/2016 - 07/2003
6	Insulin-Like Growth Factor II (Somatomedin A)IBA 06/2016 - 11/2007
5	Protein Kinases (Protein Kinase)IBA 04/2014 - 11/2007
5	HLA-A*02:01 antigenIBA 10/2006 - 12/2004
4	HLA-A Antigens (HLA-A)IBA 05/2018 - 12/2004
4	VaccinesIBA 05/2018 - 12/2012
4	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2015 - 06/2005
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2014 - 10/2006
4	HLA-A24 AntigenIBA 04/2011 - 07/2004
3	regorafenibIBA 11/2023 - 01/2020
3	pembrolizumabIBA 09/2023 - 01/2022
3	NivolumabIBA 09/2023 - 05/2021
3	B7-H1 AntigenIBA 01/2023 - 02/2021
3	Carcinoembryonic AntigenIBA 12/2022 - 07/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2022 - 01/2021
3	EnzymesIBA 12/2021 - 08/2009
3	Gemcitabine FDA Link 07/2015 - 11/2008
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2014 - 10/2008
3	Cadherins (E-Cadherin)IBA 08/2012 - 10/2008
3	Insulin-Like PeptidesIBA 08/2009 - 11/2007
2	HomocysteineIBA 05/2024 - 05/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2023
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2023 - 11/2008
2	Bevacizumab (Avastin)FDA Link 09/2023 - 01/2019
2	LigandsIBA 09/2023 - 01/2023
2	AntibodiesIBA 09/2023 - 12/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 05/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2012
2	Therapeutic UsesIBA 12/2022 - 02/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 01/2016
2	Alanine Transaminase (SGPT)IBA 11/2022 - 06/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2022 - 06/2021
2	Imatinib Mesylate (Gleevec)FDA Link 07/2022 - 01/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 01/2019
2	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2019
2	arginyl- phenylalanyl- valyl- prolyl- aspartyl- glycyl- asparagyl- arginyl- isoleucineIBA 07/2015 - 12/2012
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2014 - 08/2013
2	KinesinsIBA 08/2013 - 01/2012
2	Small Interfering RNA (siRNA)IBA 08/2006 - 08/2005
1	Volatile Fatty AcidsIBA 05/2024
1	isobutyric acidIBA 05/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024
1	Red Fluorescent ProteinIBA 01/2024
1	Green Fluorescent ProteinsIBA 01/2024
1	MethyltransferasesIBA 12/2023
1	Temozolomide (Temodar)FDA LinkGeneric 12/2023
1	Phosphates (Orthophosphate)IBA 11/2023
1	Cytotoxins (Cytolysins)IBA 05/2023
1	IsotopesIBA 01/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023

Therapy/Procedure

27	Therapeutics 05/2024 - 03/2002
25	Immunotherapy 05/2024 - 07/2003
12	Drug Therapy (Chemotherapy) 01/2024 - 02/2005
3	Lasers (Laser) 01/2024 - 03/2021
3	Aftercare (After-Treatment) 01/2024 - 09/2019
2	Oral Administration 05/2024 - 01/2023
2	Radiotherapy 09/2023 - 07/2012
1	Combination Drug Therapy (Combination Chemotherapy) 01/2024
1	Laparotomy 01/2024